Mirabegron for brain bleeding soon after symptoms start
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial studies whether mirabegron can improve safety and outcomes after an intracerebral hemorrhage (a type of brain bleeding). Participants start treatment within 72 hours of symptom onset and are monitored for recovery and side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older.
- Your brain CT scan shows a single bleeding area measuring about 5 to 30 mL.
- Your symptoms started (or you were last normal) within the last 72 hours.
- Your Glasgow Coma Scale score is at least 6 but less than 12.
- Before this event, you were independent in daily life, with an mRS score under 1.
- You can sign consent and follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how people recover after surgery for a brain bleed (intracerebral hemorrhage). It aims to find the best timing for treatment to improve recovery. If you have had a brain bleed and are eligible for surgery, you may be able to join.
This trial studies whether a minimally invasive, image-guided endoscopic procedure can remove blood after a specific type of brain bleed. It may help reduce symptoms and improve outcomes compared with standard care, but you must meet timing and medical criteria.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
This trial tests a type of keyhole surgery called neuroendoscopic surgery to remove large blood clots in the brain. It may help people who have had a serious brain bleed and need urgent surgery.
This trial tests if the antibiotic minocycline can help people recover after a spontaneous brain bleed (intracerebral hemorrhage). It is for patients who have a moderate-sized bleed and are within 48 hours of symptoms starting.
This trial tests a less invasive surgery to remove small blood clots (20–30 ml) in the basal ganglia, a deep part of the brain. It may help people who are awake but have a reduced level of consciousness after a recent brain bleed.
Hear when a new Intracerebral Haemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.